Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xixi Xiang

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of International Medical Research|July 13, 2018
Knowledge database assisted gene marker selection for chronic lymphocytic leukemiaXixi Xiang, Yu-Ping Wang, Hongbao Cao, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2011
Myelodysplastic syndrome associated with clopidogrel: a case reportMei Li, Tao Chen, Chun Liang, et al.
Leukemia & Lymphoma|September 18, 2010
An infrequent relapse of multiple myeloma predominantly manifesting as light chain escape: clinical experience from two Chinese centersXiaoyan Qu, Li Zhang, Weijun Fu, et al.
BMC Medical Genetics|October 23, 2020
Deep vein thrombosis inhibitor may play a therapeutic role in post-stroke patientsXixi Xiang, Di Yuan, Peiyan Kong, et al.
Hematological Oncology|October 24, 2025
Identification of Copy Number Alterations From Shallow Whole-Genome Sequencing in Multiple MyelomaJiali Li, Shaobing Gao, Zhenling Li, et al.
Acta Biochimica Et Biophysica Sinica|July 19, 2018
PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expressionXixi Xiang, Di Yuan, Yao Liu, et al.
Hematology (Amsterdam, Netherlands)|May 14, 2019
Upfront autologous hematopoietic stem cell transplantation in patients with high-risk stage III to IV Hodgkin lymphoma: a multicenter retrospective cohort studyLi Gao, Xixi Xiang, Cheng Zhang, et al.
International Journal of Hematology|April 8, 2024
Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomasSha Zhou, Jun Rao, Xiangyu Ma, et al.
PPAR Research|July 5, 2023
Significance of PPARA as a Treatment Target for Chronic Lymphocytic LeukemiaXixi Xiang, Fu Li, Sha Zhou, et al.
Transplant Immunology|November 3, 2023
Thrombopoietin receptor agonists for refractory thrombocytopenia in patients after autologous hematopoietic stem cell transplantationDan Wang, Tao Lang, Hanqing Zeng, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of International Medical Research|July 13, 2018
Knowledge database assisted gene marker selection for chronic lymphocytic leukemiaXixi Xiang, Yu-Ping Wang, Hongbao Cao, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2011
Myelodysplastic syndrome associated with clopidogrel: a case reportMei Li, Tao Chen, Chun Liang, et al.
Leukemia & Lymphoma|September 18, 2010
An infrequent relapse of multiple myeloma predominantly manifesting as light chain escape: clinical experience from two Chinese centersXiaoyan Qu, Li Zhang, Weijun Fu, et al.
BMC Medical Genetics|October 23, 2020
Deep vein thrombosis inhibitor may play a therapeutic role in post-stroke patientsXixi Xiang, Di Yuan, Peiyan Kong, et al.
Hematological Oncology|October 24, 2025
Identification of Copy Number Alterations From Shallow Whole-Genome Sequencing in Multiple MyelomaJiali Li, Shaobing Gao, Zhenling Li, et al.
Acta Biochimica Et Biophysica Sinica|July 19, 2018
PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expressionXixi Xiang, Di Yuan, Yao Liu, et al.
Hematology (Amsterdam, Netherlands)|May 14, 2019
Upfront autologous hematopoietic stem cell transplantation in patients with high-risk stage III to IV Hodgkin lymphoma: a multicenter retrospective cohort studyLi Gao, Xixi Xiang, Cheng Zhang, et al.
International Journal of Hematology|April 8, 2024
Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomasSha Zhou, Jun Rao, Xiangyu Ma, et al.
PPAR Research|July 5, 2023
Significance of PPARA as a Treatment Target for Chronic Lymphocytic LeukemiaXixi Xiang, Fu Li, Sha Zhou, et al.
Transplant Immunology|November 3, 2023
Thrombopoietin receptor agonists for refractory thrombocytopenia in patients after autologous hematopoietic stem cell transplantationDan Wang, Tao Lang, Hanqing Zeng, et al.
Pageof 2